Early Edition on Newstalk ZBEarly Edition on Newstalk ZB

Rosamund Hill: Neurologist on the new anti-migraine medication costing kiwis $300 a month

View descriptionShare

New and effective anti-migraine drugs aren't publicly funded in New Zealand, costing those with chronic migraine nearly $300 a month. 

An Otago University survey suggests almost half of those with the disease meet the criteria for severe disability.  

Some report paralysis on one side of the body and loss of coherent speech. 

Neurologist Rosamund Hill told Mike Hosking that the medicine's publicly funded in Australia. 

She says it's feasible for Pharmac to identify those at the worst end of the spectrum, and how these drugs would significantly change their lives. 

LISTEN ABOVE 

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Early Edition on Newstalk ZB

    2,544 clip(s)

Early Edition on Newstalk ZB

Don't risk not knowing what's going around New Zealand and the world - catch up with interviews from 
Social links
Follow podcast
Recent clips
Browse 2,547 clip(s)